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CUGBP1 and MBNL1 are developmentally regulated RNA-binding proteins that are causally associated
with myotonic dystrophy type 1. We globally determined the in vivo RNA-binding sites of CUGBP1 and
MBNL1. Interestingly, CUGBP1 and MBNL1 are both preferentially bound to 39 UTRs. Analysis of
CUGBP1- and MBNL1-bound 39 UTRs demonstrated that both factors mediate accelerated mRNA decay
andtemporalprofilesofexpressionarrayssupportedthis.RoleofCUGBP1onacceleratedmRNAdecayhas
been previously reported, but the similar function of MBNL1 has not been reported to date. It is well
established that CUGBP1 and MBNL1 regulate alternative splicing. Screening by exon array and validation
by RT-PCR revealed position dependence of CUGBP1- and MBNL1-binding sites on the resulting
alternative splicing pattern. This study suggests that regulation of CUGBP1 and MBNL1 is essential for
accurate control of destabilization of a broad spectrum of mRNAs as well as of alternative splicing events.
I
n recent years, new technologies, such as microarray analysis and high throughput sequencing, have dramat-
ically changed our knowledge on gene expression and revealed that extensive regulation takes place during
posttranscriptional RNA processing
1. Numerous RNA processing elements and regulatory RNA-binding
proteins play together in a finely tuned interplay to ensure that different mRNAs are made from the primary
transcript from a gene and are present in the right cell at the right time and in the correct amounts. Such complex
regulation is of course vulnerable and a rapidly increasing number of human diseases are now known to be caused
by misregulated RNA processing
2. An intriguing example where this kind of disease mechanism is in operation is
myotonic dystrophytype 1 (DM1),where aberrantregulation of twoRNA-binding proteins,CUG-binding protein
1 (CUGBP1) and muscleblind-like 1 (MBNL1) co-operationally cause some of the disease symptoms. DM1 is the
most common form of myotonic dystrophy (DM), and is caused by an expansion of CTG-repeats in the 39
untranslated region (UTR) of the DM protein kinase gene (DMPK) on chromosome 19
3–5.D M 1i sam u l t i s y s t e m i c
disorder and the clinical features include myotonia, muscle degeneration, heart failure, ocular cataracts, impaired
glucose tolerance, and mental retardation
6,7. A dominant negative effect of the DMPK mutant allele through RNA
gain-of-function has been proposed as the molecular disease mechanism. Many studies support a mechanism
wheretoxic DMPK RNAwithexpanded CUG repeats binds to and sequestersproteins thatare important for RNA
metabolism including transcription, RNA transport, alternative splicing, translation, and yet unknown processes
6.
The expanded CUG repeats in the DMPK mRNA bind to and sequestrate MBNL1 in discrete nuclear foci, which
results indepletion of functionalMBNL1
8,9. By a yet unknown mechanismthe expanded CUG repeats also activate
protein kinase C (PKC), which phosphorylates and stabilizes CUGBP1
10. Thus, the expanded CUG repeats
contribute to DM1 pathogenesis by causing loss of MBNL1 and gain of CUGBP1 activity
11.
Both CUGBP1 and MBNL1 regulate postnatal transitions in alternative splicing patterns during striated
muscle development
9,12,13. Representative targets of CUGBP1 splicing regulation, which are misregulated in
DM1 striated muscles, include genes for cardiac troponin T (TNNT2)
14,15, insulin receptor (INSR)
16, and chloride
channel1(CLCN1)
15,17.MBNL1containsfourCCCH-typezincfingersthatrecognizeaYGCYmotifthatisindeed
observed inthe CUG repeat(CUGCUG)
18–21. Micedeficient inMbnl1 showaberrantsplicing ofClcn1, Tnnt2,a n d
Tnnt3,but notInsr
22.Veryrecently, MBNL1was showntoregulateBIN1alternativesplicing,and dysregulationof
BIN1 splicing in DM1 muscles was suggested to be part of the disease pathology resulting in muscle weakness
23.
Besides an important role in splicing regulation, CUGBP1 mediates mRNA decay of short-lived transcripts
by interaction with GU-rich elements in the 39 UTR
24–27. In addition, CUGBP1 increases the translation of
CDKN1A
28 and Mef2a
29. In contrast to the multiple functionalities in posttranscriptional gene regulation of
CUGBP1, MBNL1 has so far been exclusively recognized as a splicing regulatory trans-factor.
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immunoprecipitation (HITS-CLIP)
30 is a new method that enables
globalmappingoftargetsforspecificRNA-bindingproteinsinliving
cells, thereby shedding light on their role in regulation of RNA pro-
cessing of known and unknown targets.
In the present study, we performed HITS-CLIP analysis for
CUGBP1 and MBNL1 on the mouse myoblast cell line C2C12
to extensively characterize their RNA-binding sites and functional
roles in RNA processing. We identified position-dependence of
CUGBP1/MBNL1-binding sites in regulating exon inclusion or
skipping. Interestingly, we discovered that both CUGBP1 and
MBNL1 preferentially bind to the 39 UTR and destabilize target
mRNAs.ThispointstoanewimportantroleofMBNL1andsuggests
thatbindingtothe39UTRsanddestabilizationofmRNAarelikelyto
be a fundamental function shared by CUGBP1 and MBNL1.
Results
Genome-wide CUGBP1/MBNL1-RNA interaction maps. In order
to determine global CUGBP1/MBNL1-binding sites in vivo,w e
performed HITS-CLIP experiments using the mouse myoblast cell
line, C2C12.
InC2C12cells,CUGBP1isconstantlyexpressedthroughoutmyo-
blast differentiation, whereas expression of MBNL1 is low in undif-
ferentiated cells and gradually increases during differentiation
(Supplementary Fig. S1), as previously described
8. We thus per-
formed HITS-CLIP analysis of CUGBP1 and MBNL1 using undif-
ferentiated and differentiated C2C12 cells, respectively. We also
performed CLIP of MBNL1 using undifferentiated cells in three
independent experiments, but this yielded an insufficient amount
of RNA-protein complexes and failed to yield cDNA libraries suit-
able for high-throughput sequencing. In the HITS-CLIP analysis of
CUGBP1,ourfirstexperimentyielded34,733,815CLIPtagsof32nt,
of which 29,545,067 (85.06%) were mapped to the mm9 genome
allowing at most 2 mismatches and placing reads mapping to mul-
tiple locations to a single random site. A second CLIP experiment
yielded 10,079,185 CLIP tags of 36 nt, of which 8,516,256 (84.49%)
were mapped. In the first MBNL1 CLIP experiment, we obtained
13,218,685 CLIP tags, of which 11,044,152 (83.55%) were mapped,
whilethesecondCLIPexperimentyielded13,474,600CLIPtagswith
11,455,886 (85.02%) tags mapped to the mm9 genome. For the ana-
lysis of binding motif and binding region annotation, we selected
onlyreadsthatwerealigneduniquelyinthegenomeandremovedall
potentialPCRduplicatesbycollapsingreadswithanidentical59start
into a single read. This resulted in 177,013 and 130,828 CLIP tags
from the two CUGBP1 CLIP experiments, while the two MBNL1
experiments yielded 59,156 and 583,841 CLIP tags respectively.
In aneffort to confirmthe specificity of our CLIP experiments, we
performed CLIP analysis of polypyrimidine tract-binding protein
(PTB), a multifunctional RNA-binding protein, using undifferenti-
atedmouseC2C12cells.Weidentified12,841,778CLIPtagsofwhich
11,184,829 (87.10%) were mapped to the mouse mm9 genome.
Removal of non-uniquely aligned reads and PCR duplicates yielded
307,995 unambiguous CLIP tags.
Consensus motifs. To determine RNA-binding motifs associated
with CUGBP1/MBNL1 in vivo, we used the motif-finding algori-
thm, Multiple EM for Motif Elicitation (MEME)
31. We used
SeqMonk to identify likely binding regions, and identified 1,841
CUGBP1-binding regions and 302 MBNL1-binding regions. Com-
parison of SeqMonk’s maximum depth scores between samples
indicates that binding regions in each replicated experiment are
highly overlapping, while PTB binding regions did not overlap
with those of the other four CLIP experiments (Supplementary
Fig. S2). The lower number of identified MBNL1 regions supported
by two independent experiments (Supplementary Fig. S2b) was likely
due to the large difference in the number of CLIP tags in the two
MBNL1 experiments. The regions demonstrate enrichment of GU-
rich motifs for CUGBP1 and YGCY-containing motifs for MBNL1
(Fig. 1).
Our in vivo binding motifs are in accordance with previously
suggested binding motifs for CUGBP1
25,32 and MBNL1
21,33–35.W e
identified 1,824 PTB binding regions in the mouse genome and
detected a CU-rich motif, which is essentially identical to the motif
for PTB recently identified by HITS-CLIP analysis of a human cell
line
36.
We also analyzed the CUGBP1 and MBNL1 motifs enriched in
regions containing reads with multiple potential mapping locations
(Supplementary Fig. S3), and compared them with the motifs with
unique mapping (Fig. 1). Following removal of potential PCR dupli-
cates,weobserved699,382tagsthatwerenon-uniquelyalignedinthe
1st CUGBP1 CLIP experiment, 219,128 tags in the 2nd CUGBP1
CLIP experiment,105,432and 216,882 tagsin thetwoMBNL1 CLIP
experiments respectively and finally 851,324 tags in the PTB CLIP
experiment. We observed that enriched motifs in these regions (Sup-
plementary Fig. S3) are very similar to the CUGBP1 and MBNL1
motifs enriched in the binding regions containing uniquely aligned
reads (Fig. 1), suggesting that these regions share the same properties
as the uniquely aligned regions and that they may contain functional
binding sites.
HITS-CLIP analysis of splicing targets. We next studied the effects
of CUGBP1/MBNL1 binding on alternative splicing. CUGBP1 tags
are clustered in intronic regions flanking alternative rather than
Figure 1 | Bindingmotifanalysis. WebLogosofconsensusbindingmotifs
of CUGBP1, MBNL1, and PTB generated by the MEME motif analysis
tool.Thelikelihoodoffindingtheindicatedmotifbychanceisindicatedas
an E-value.
www.nature.com/scientificreports
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intronic regions flanking alternative exons, and are also enriched in
alternative and constitutive exons. In order to investigate if and how
CUGBP1/MBNL1 binding around splice sites regulate alternative
splicing, we knocked down these factors by siRNA in undif-
ferentiated C2C12 cells (Supplementary Fig. S4a). We analyzed
alterations of splicing globally using the Affymetrix Mouse Exon
1.0 ST Array (GEO accession number, GSE29990) and identified 8
CUGBP1-responsiveand24MBNL1-responsiveexons(Supplemen-
tary Table 1, Figs. S5 and S6abc). We also analyzed 29 CUGBP1-
tagged and 51 MBNL1-tagged exons/introns known to be alternatively
spliced according to the ENSEMBL version e!61, and identified 16
CUGBP1-responsive and 21 MBNL1-responsive exons by RT-PCR
(Supplementary Figs. S5 and S6abc). We made the compiled dataset
C, which is comprised of the 24 CUGBP1-regulated exons (15
skipped and 9 included), as well as the compiled dataset M con-
sisting of the 45 MBNL1-regulated exons (25 skipped and 20
included). The datasets include 1 and 9 previously identified target
exons of CUGBP1 and MBNL1, respectively (Supplementary
Fig. S5). In addition, 9 exons are shared between datasets C and
M. Mbnl1 siRNA sufficiently suppressed MBNL1 expression up to
day 3 after differentiation (Supplementary Fig. S4b), and we observed
that as many as 44 of the 45 MBNL1-regulated exons in dataset M
respond similarly to MBNL1 knockdown in both differentiated and
undifferentiated cells (Supplementary Figs. S4 and S5).
We also made dataset M2 that includes 26 additional MBNL1-
dependent cassette exons (15 skipped and 11 included) that were
previously identified in skeletal muscle of MBNL1 knockout mice
Figure 2 | Mapping of CLIP-tags on exon-intron structures. (a) Distributions of CLIP-tags on constitutively or alternatively spliced exons and the
flankingintronicregions.Theabscissaindicatesanintron-exon-intronstructure.Thesizesofalltheexonsarenormalizedto150nucleotides.Numbersof
exonic CLIP-tags are also normalized accordingly. Intronic CLIP-tags within 500 nucleotides upstream or downstream of exons are indicated. The
number of CLIP-tags is normalized for the number of transcripts belonging to either category of constitutive and alternative exons. (b) Normalized
complexity mapofCUGBP1 at CUGBP1-dependent splice sites.Twenty-fourCUGBP1-regulated splicing events indataset C inundifferentiated C2C12
cells are compiled. (c) Normalized complexity map of MBNL1 at MBNL1-dependent splice sites. Forty-four MBNL1-regulated splicing events in
differentiated C2C12 cells in dataset M are compiled. (d) Normalized complexity map of CUGBP1 at MBNL1-dependent splice sites. Sixty MBNL1-
regulated splicing events in undifferentiated C2C12 cells in datasets M and M2 are compiled. (e) Normalized complexity map of MBNL1 at CUGBP1-
dependentsplicesites.Twenty-fourCUGBP1-regulatedsplicingeventsinundifferentiated C2C12cellsindatasetCarecompiled.Shadedareasrepresent
an average of 100 sets ofnormalized complexity of50 (b, c, and d) and 15 (e) randomly selected constitutive exons. Arrows indicate representative peaks
that are explained in Results. Graphs represents results ofthe 2nd CLIP experiments for both CUGBP1 and MBNL1. Resutls of the 1st CLIP experiments
are shown in Supplmentary Fig. S7.
www.nature.com/scientificreports
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33, and found that 18 exons are similarly
regulated by Mbnl1 knockdown in undifferentiated C2C12 cells
(Supplementary Fig. S6d and Table S2).
We combined datasets C and M into a single composite pre-
mRNA and made integrated RNA maps from our HITS-CLIP reads
mapped to the corresponding genomic regions as previously
described for Nova
30 and PTB
36. This showed that CUGBP1 binding
to upstream intronic regions facilitates exon skipping, whereas
CUGBP1 binding to downstream intronic regions promotes exon
inclusion (closed arrows in Fig. 2b and Supplementary Fig. S7a).
Results of the 2nd experiments are shown in Fig. 2 and those of
the 1st experiments are in Supplementary Fig. S7. In contrast,
although the binding sites of MBNL1 are more diffusely distributed
and less abundant in regions flanking splice sites (Fig. 2c), MBNL1
binding close to the 39 end of the downstream intron induces exon
skipping (closed arrow in Fig. 2c and Supplementary Fig. S7b). The
presence of a similar peak in dataset M2 (closed arrow in Supple-
mentary Fig. S7c) further supports this observation.
We next analyzed the interaction between CUGBP1 and MBNL1
in splicing regulation. We made an RNA map of CUGBP1-binding
sites in MBNL1-regulated exons from datasets M and M2 (Fig. 2d
and Supplementary Fig. S7e), as well as an RNA map of MBNL1-
bindingsitesinCUGBP1-regulatedexonsfromdatasetC(Fig.2eand
Supplementary Fig. S7f). Both RNA maps demonstrate the presence
of CUGBP1 clusters in MBNL1-responsive exons and vice versa,
which suggests that CUGBP1 and MBNL1 are likely to regulate
alternative splicing of some of the same exons.
MBNL1 and CUGBP1 both preferentially bind to the 39 UTR.
MBNL1 has so far solely been categorized as an exon/intron-
binding splicing regulatory protein
6, but to our surprise we found
that the majority (55%) of MBNL1-binding regions are located
in 39 UTRs (Fig. 3a). The same pattern with preferential binding
(53%) in 39 UTRs is observed for CUGBP1, while only 2% of PTB
binding regions are located in 39 UTRs (Fig. 3a). Similarly, when
HITS-CLIP tags are mapped to the size-normalized positions of all
the genes in the mouse genome, CUGBP1 and MBNL1 CLIP tags, but
not PTB CLIP-tags, are enriched close to the 39ends of genes (Fig.3b).
Additionally, 610 39 UTRs, which constitutes 28.7% of the CUGBP1-
tagged 39 UTRs and 17.4% of the MBNL1-tagged 39 UTRs, are shared
Figure 3 | Enrichment of CUGBP1 and MBNL1 CLIP-tags in the 39 UTR. (a) Distributions of CUGBP1, MBNL1, and PTB binding regions. Binding
regions are mapped to CDS (coding sequence), 59 and 39 UTRs, introns, intergenic regions (incl. tRNA and rRNA genes), or antisense within genes
according to the UCSC knownGene annotation of the NCBI Build 37.1 mouse genome (mm9). Pie-charts show ratios of binding regions mapped to the
indicated regions. (b) Distributions of CUGBP1, MBNL1, and PTB CLIP-tags mapped to the relative positions of all the mouse genes. The relative
positions of the genes are shown in percentages of the gene length in abscissa. The broken lines represent 15,638 genes with constitutive transcriptional
startandendsites(Cons),andthesolidlinesrepresent7,477geneswithalternativetranscriptionalstartorendsite(Alt).(c)Venndiagramofthenumbers
of genes with CUGBP1-, MBNL1-, and PTB-binding regions within the 39 UTR. Binding regions were identified using the SeqMonk software.
www.nature.com/scientificreports
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both CUGBP1 and MBNL1 preferentially bind to 39 UTRs, indicating
that this is a key function of both proteins in RNA processing. This
suggests that the functional repertoire of MBNL1 should be expanded
and that MBNL1, from being primarily regarded as regulator of
alternative splicing, should also be considered as an important
regulator of 39 UTR-mediated processes, such as mRNA stability/
degradation.
MBNL1 destabilize mRNAs. To analyze the function of CUGBP1/
MBNL1 binding to 39 UTRs, we made luciferase reporter constructs
harboring CUGBP1/MBNL1-binding sites in the 39 UTR. Since no
CLIP tags were observed in the 39 UTR of Gapdh (Supplementary
Fig. S8), we made a luciferase-Gapdh 39 UTR expression vector, and
then inserted 12 repeats of GT and 7 repeats of CTG immediately
afterthestopcodonofluciferasetointroduceaCUGBP1-bindingsite
(GU rich motif) and an MBNL1-binding site (YGCY motif),
respectively (Fig. 4a). We also inserted 12 AC repeats as a control.
Due to the high expression level of CUGBP1 in C2C12 cells we used
HEK293 cells for transient transfection of these reporter constructs
along with CUGBP1/MBNL1 expression vectors. For the constructs
with Gapdh 39 UTR alone or with AC repeats inserted, over-
expression of CUGBP1 or MBNL1 had no effect on luciferase
activity (Fig. 4b). For the GT repeat construct, overexpression of
CUGBP1 decreased the luciferase activity, but MBNL1 had no
effect. For the CTG repeat construct overexpression of MBNL1
dramatically decreased the luciferase activity, and also overex-
pression of CUGBP1 significantly reduced luciferase activity
(Fig. 4b). In order to shed light on the mechanism underlying the
observed decrease in luciferase activity we investigated the decay
of luciferase mRNA. The SV40 promoter of the luciferase reporter
constructs was replaced with a tet-repressible promoter, and
HEK293 Tet-off cells were transiently transfected with these
constructs. Doxycycline was added to the medium to stop tran-
scription of the tet-responsive promoter, and the temporal profiles
of luciferase and GAPDH mRNA levels were measured. Over-
expression of MBNL1 together with the CTG repeat reporter
construct resulted in highly increased decay of luciferase mRNA
and CUGBP1 overexpression together with the GT repeat reporter
construct also increased mRNA decay. Overexpression of either
protein together with the Gapdh 39 UTR control construct did not
alter mRNA decay (Fig. 4c). These data demonstrate that binding of
CUGBP1 and MBNL1 to the 39 UTR promotes mRNA decay. To
examine whether CUGBP1 and MBNL1 regulate decay of endo-
genous mRNAs, we next analyzed mRNA stability in actinomycin
D treated C2C12 cells by expression arrays following siRNA knock
down of CUGBP1 or MBNL1 (GEO accession number, GSE27583).
To identify genes with reliable half-life estimates, we restricted
our analysis to 195 transcripts using three conditions: (i) half-life
between 2.5–5 hrs; (ii) correlation coefficient of fitting to an
exponential decay greater than 0.9; and (iii) RMA-normalized
signal values more than 100 at all time points. The median half-life
ofallthetranscriptsmatchingthesecriteriainthecontrolis3.56 hrs,
whereas those from CUGBP1- and MBNL1-knocked down cells
are significantly prolonged to 3.91 hrs and 3.73 hrs, respectively
(Fig. 5a). We chose four additional representative mRNAs with a
cluster of either CUGBP1- or MBNL1-tags in the 39UTR, and
confirmed by real time PCR that knockdown of either CUGBP1 or
MBNL1 results in approximately two-fold increase in mRNA half-
life of these target mRNAs (Fig. 5b). The half-lives of 100 out of 195
transcripts are prolonged both by knockdown of CUGBP1 and
MBNL1, suggesting overlapping activity in the regulation of
mRNA decay by CUGBP1 and MBNL1. We next analyzed the
relationship between change in mRNA half-life and coverage of
HITS-CLIP tags in the 39 UTRs. We found that genes displaying
prolongation of half-lives in response to CUGBP1 knockdown
harbors more CUGBP1-tags in their 39 UTRs, compared to those
displaying shortening of half-lives (Fig. 5c). Similarly, genes that
display prolongation of their half-lives in response to MBNL1
knockdown have more MBNL1-tags in their 39 UTRs (Fig. 5c).
Gene Ontology analysis of CUGBP1/MBNL1-bound 39 UTRs
revealed that the terms ‘cytoskeletal protein binding, ‘transcription
factor binding’ and ‘RNA binding’ are significantly overrepresented
for CUGBP1- and MBNL1-bound genes (Table 1).
Figure 4 | Decay of luciferase mRNA by overexpression of CUGBP1/MBNL1. (a) Schemes of luciferase reporter plasmids harboring Gapdh 39 UTR.
EachconstructwasmadecarryingeitherSV40ortet-responsivepromoter.(b)LuciferaseactivityafteroverexpressionofCUGBP1/MBNL1.HEK293cells
were transfected with the indicated SV40-driven luciferase reporter constructs. Luciferase activity is normalized for the transfection efficiency using co-
transfection of pRL/SV40. (c) Decay of luciferase mRNA after overexpression of CUGBP1/MBNL1. HEK293 Tet-off cells were transfected with the
indicatedtet-responsivepromoter-drivenluciferasereporterconstructs.Doxycyclinewasaddedtothemediumtostoptranscriptionattime0.Temporal
profilesofluciferasemRNAdecaywerequantifiedbyrealtimeRT-PCRandarenormalizedforGapdhmRNAlevels.Allexperimentsweretriplicated,and
the mean and s.d. are indicated (* p , 0.05; ** p , 0.01).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 209 | DOI: 10.1038/srep00209 5Figure 5 | GlobalanalysisofmRNAdecaybyexpressionarrayofC2C12cellstreatedwithCUGBP1/MBNL1siRNA. (a)Half-livesofmRNAsinC2C12
cellswiththeindicatedsiRNAs.Redlinesrepresentmeansand95%confidenceintervals.**p,0.01and***p,0.001.(b)Real-timeRT-PCRanalysisof
the stability of four representative endogenous mRNAs, which were detected by expression arrays. CLIP-tag distributions are shown above each gene
structure. C2C12 cells were treated with either control (ctl), CUGBP1 (Cug), or MBNL1 (Mb) siRNA. Actinomycin D was added to the medium to stop
transcriptionattime0.Temporalprofilesofdecayoftheindicatedgeneswereanalyzedbyreal-timeRT-PCRandarenormalizedforGapdhmRNAlevels.
Allexperimentsweretriplicated,andthemeanands.d.areindicated(*p,0.05and**p,0.01).(c)Tagcountsinthe39UTRofeachgeneareplottedin
twocategoriesofprolonging(up)andshortening(down)ofhalf-livesafterMBNL1andCUGBP1siRNAs.Redlinesrepresentmeansand95%confidence
intervals. ** p , 0.01. Tag counts were normalized by the gene expression level at 0 h of cells treated with control siRNA.
Table 1 | The five most frequent Gene Ontology terms of mRNAs that are bound by CUGBP1 and MBNL1 to the 39 UTR
CLIP data GO ID Term P Value
CUGBP1 GO:0008092 cytoskeletal protein binding 1.58E-06
GO:0003723 RNA binding 1.40E-04
GO:0008134 transcription factor binding 9.65E-04
GO:0051082 unfolded protein binding 0.003184
GO:0019904 protein domain specific binding 0.006603
MBNL1 GO:0008092 cytoskeletal protein binding 7.31E-20
GO:0008134 transcription factor binding 2.20E-08
GO:0003723 RNA binding 0.001893
GO:0019899 enzyme binding 0.002046
GO:0032553 ribonucleotide binding 0.004210
We utilized the mRNAs that have more than 8-fold coverage of CLIP tags in their 39UTR for the analysis by DAVID
53,54.
www.nature.com/scientificreports
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asymmetric morphogenesis
37,38 and it is also deeply implicated in
myogenesis during mouse embryonic development
39–41. We found
that the decay of Pitx2 mRNA is prolonged by knocking down
MBNL1, but not CUGBP1 in undifferentiated C2C12 cells (Fig. 6b
and c). This is consistent with the fact that Pitx2 harbors a much
higher number of MBNL1-CLIP tags than that of CUGBP1-CLIP
tags in the 39 UTR (Fig. 6a). We also observed that down regulation
of both CUGBP1 and MBNL1 decreases the decay of Myod1 and
Mbnl2 mRNA, but not that of Gapdh mRNA (Supplementary
Fig. S8). Similarly, down regulation of CUGBP1 decreases the decay
of other myogenic transcription factors such as Myog and Mef2a
mRNAs, and also of Cugbp2 (Supplementary Fig. S9). Further-
more, knockdown of CUGBP1 and MBNL1 prolongs decay of
Mbnl1 and Cugbp1 mRNAs, respectively, suggesting a mechanism
for cross-regulation of expression of MBNL1, CUGBP1, and their
family proteins (Supplementary Fig. S8).
ToanalyzemoredirectlytheroleofMBNL1bindingtothe39UTR
in regulation of mRNA decay, we examined the mRNA stability of
fireflyluciferasefusedwiththe39UTRofPitx2(Fig.6a).Thereare11
YGCY motifs in the 39 UTR of Pitx2, and 4 of the 11 motifs have
MBNL1-CLIP tags. We introduced artificial mutations in these 4
motifs to prevent binding of MBNL1 (Fig. 6a). Consistent with the
proposed role for MBNL1 in mRNA decay, we observe that disrup-
tion of the MBNL1-binding motifs in the Pitx2-39 UTR abolished
responsiveness to MBNL1 knockdown (Fig. 6d). Furthermore,
immunoblots demonstrated that MBNL1-knockdown enhanced
expressionofendogenousPITX2inC2C12cells(Fig.6e).Thesedata
suggest that MBNL1 promotes decay of Pitx2 mRNA and thereby
represses expression of the PITX2 protein.
Taken together, all of our data are consistent with a model where
CUGBP1andMBNL1facilitatemRNAdecaythroughbindingtothe
39 UTR of target genes.
Discussion
CUGBP1 and MBNL1 are developmentally regulated RNA-binding
proteins that are causally associated with myotonic dystrophy type 1.
In this study, we show that both CUGBP1 and MBNL1 preferentially
bind to 39 UTRs and destabilize the bound mRNAs. In particular, we
showthat CUGBP1 and MBNL1destabilize myogenicdifferentiation
factors and RNA-binding proteins. In addition, our results confirm
and significantly expand the current knowledge of the splicing-
regulatory effects of CUGBP1 and MBNL1. Taken together, the data
from the present study indicates that CUGBP1 and MBNL1 are
closely related and cross regulate alternative splicing and mRNA
decay.
MBNL1bindingto 39UTRs hasnotbeenpreviously reported. We
show for the first time that MBNL1 binds to 39 UTRs and promotes
mRNA decay in both artificial constructs and in endogenous genes.
We also demonstrate by expression arrays that both CUGBP1 and
MBNL1 facilitate mRNA decay by binding to 39 UTRs. The present
studydemonstratesglobalinvivointeractionsbetweenCUGBP1and
39 UTRs and reveals that CUGBP1 also preferentially binds to 39
UTR rather than exons/introns. We provide in vivo evidence that
CUGBP1 facilitates mRNA decay of a broad spectrum of genes in
addition to the previously reported genes
25–27,42–44.
Interestingly, we find that MBNL1 promotes decay of Cugbp1
mRNA and that CUGBP1 promotes decay of Mbnl1 mRNA, and
thatthisisassociatedwithcorrespondingchangesattheproteinlevel
during differentiation of C2C12 cells (Supplementary Fig. S4b). This
may suggest that expression of CUGBP1 and MBNL1 are mutually
regulated in myogenic differentiation. Kuyumcu-Martinez and col-
leagues report that expanded CUG repeats of DMPK through an
unknown mechanism leads to phosphorylation and thereby to sta-
bilization of CUGBP1 in DM1 myoblasts
10. Our studies additionally
suggest that loss of MBNL1 in DM1 could lead to decreased decay of
CUGBP1 mRNA and hence to further increase of CUGBP1 activity.
Although CUGBP1 is not upregulated in adult MBNL1-knockout
mice, this mechanism could lead to increased misregulation of splic-
ing and decay of the mRNAs of target genes in embryonic develop-
ment that culminates in the DM1 phenotype.
We find that binding sites for CUGBP1 and MBNL1 are enriched
around alternative cassette exons (Fig. 2a). The binding sites for
CUGBP1 are prominent in adjacent intronic regions flanking
alternative exons. Our functional analysis reveals that binding of
CUGBP1 to the upstream intron facilitates exon skipping, whereas
Figure 6 | MBNL1 binds to 39 UTR of Pitx2 and facilitates decay of Pitx2
mRNA. (a) Distributions of MBNL1 CLIP-tags in the Pitx2-gene
structure,andschemesofluciferasereporterplasmidsharboringwild-type
(Pitx2-3UTR) and mutated (mut-3UTR) 39 UTRs of Pitx2. Red bars
indicate locations of native YGCY motifs and yellow bars indicate those of
mutated YGCY motifs. Individual mutations disrupting YGCY motifs are
shown at the bottom. We introduced U at the 2nd YGCY motif to prevent
formation of AU and AC repeats, which constitute a potential binding site
of Hu proteins and hnRNP L, respectively. (b and c) Decay of endogenous
Pitx2mRNAbysiRNA-mediatedknockdownofCUGBP1(b)andMBNL1
(c). C2C12 cells were treated with either control (ctl), CUGBP1 (Cug) or
MBNL1 (Mb) siRNA. Actinomycin D was added to the medium to stop
transcription at time 0. Temporal profiles of decay of the indicated genes
were analyzed by real-time RT-PCR and were normalized for Gapdh
mRNA levels. All experiments were triplicated, and the mean and s.d. are
indicated (* p , 0.05; ** p , 0.01; *** p , 0.001). (d) Decay of luciferase
mRNA in the Pitx2-3UTR and mut-3UTR constructs after either control
(ctl) or MBNL1 (Mb) siRNA in TetON-C2C12 cells. Culture medium was
replaced by medium without doxycycline to stop transcription at time 0.
Temporal profiles of luciferase mRNA decay are quantified by real-time
RT-PCRandarenormalizedforGapdhmRNAlevels.Allexperimentswere
triplicated, and the mean and s.d. are indicated (** p , 0.01). (e)
Immunoblot of PITX2 in undifferentiated C2C12 cells at 48 hrs after
transfection of MBNL1 siRNA.
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Interestingly, similar regulation of alternative splicing has been
observed for NOVA, FOX2 and PTB
30,45,46, indicating the presence
of a common underlying mechanism shared by these proteins.
In contrast to CUGBP1, MBNL1 tags are also enriched in coding
exons.Untilnow,splicingcis-elementsofMBNL1havebeenmapped
exclusivelytointrons,andnoexoniccis-elementhasbeenreportedto
our knowledge
20,23,34,47,48. Although MBNL1 preferentially binds to
exons, MBNL1 binding to introns is enriched at alternative rather
than constitutive splice sites (Fig. 2a. This enrichment is diffusely
distributedthroughoutregionsharboring500 ntupstreamordown-
stream of alternative exons, in contrast to the prominent intronic
peaks observed for CUGBP1 tags. This could suggest that MBNL1
needs to bind simultaneously to the target exon and adjacent introns
toregulate splicing.FunctionalanalysisofMBNL1revealsthatbind-
ingofMBNL1closetothe39endofthedownstreamintronfacilitates
exon skipping, whereas no characteristic binding pattern is observed
for exons included in response to MBNL1 (Fig. 2c). PTB has also
been reported to regulate alternative splicing through binding close
to the 39 end of the downstream intron
36. In contrast to MBNL1,
however,bindingofPTBtothisregionpromotesexoninclusion.We
similarlyfindbindingofPTBtothisregioninourHITS-CLIPdatain
MBNL1-regulated exons (Supplementary Fig. S7d). Interestingly,
the MBNL1-binding motif is enriched in PTB-regulated exons
46.
MBNL1 may thus compete for binding with other splicing factors
like PTB and regulate alternative splicing events.
Post-transcriptional gene expression regulation is crucial to
achieve precise developmental and tissue-specific control of cellular
processes. Our studies reveal that CUGBP1 and MBNL1 preferen-
tially bind to the 39 UTRs of mRNAs encoding RNA-binding pro-
teins and transcription factors, which can regulate cell development.
During development of murine skeletal muscles, the nuclear level of
MBNL1 increases, while that of CUGBP1 decreases
9,12. Genes with
mRNAs that can be bound both by CUGBP1 and MBNL1 are likely
to be down-regulated by CUGBP1 in undifferentiated cells. If these
genes need to be tightly down-regulated also in differentiated cells,
MBNL1 can substitute for CUGBP1 in order to achieve continued
destabilization of the target mRNA. We conclude that finely-tuned
expression of CUGBP1 and MBNL1 may be important regulators of
myogenic differentiation through precise regulation of both alterna-
tive splicing and mRNA stability.
Methods
Antibodies. Antibodies to CUGBP1 (3B1), MHC (H300), myogenin (M225) and
PTB (N20) were purchased from Santa Cruz Biotechnology. Anti-GAPDH pAb was
purchased from Sigma. Anti-PITX2 pAb was purchased from Abcam. Anti-MBNL1
rabbit serum (A2764) was a kind gift of Dr. Charles A. Thornton at University of
Rochester. The specificity of antibodies against CUG BP1 and MBNL1 is supported
by the data in previous reports 2,3 and also by our siRNA experiments
(Supplementary Fig. S1).
Cell culture. Detailed methods are included in the Supplementary Information.
HITS-CLIP. C2C12 cells were UV-irradiated at 400 mJ and CLIP was performed as
previously described
49. High-throughput 36-bp single-end and 40-bp single-end
sequencing was performed using an Illumina Genome Analyzer II. All HITS-CLIP
data were registered in ArrayExpress with an accession number E-MTAB-414 and in
ENA with an accession number ERP000789. Detailed information is provided in the
Supplementary Information.
Bioinformaticsanalysis.Illuminareadswerefirstpreparedbyremovingthe4-bptag
and filtering sequences composed primarily of Illumina adapter. The resulting reads
were mapped to the mouse genome (NCBI Build 37.1/mm9) with defaultparameters
using the BWA
50 mapping software. To extract consensus motifs from the mapped
reads,weconsideredonlyuniquelyalignedreadsandfirstremovedduplicatereadsto
avoid potential PCR-mediated deviations in addition to bias from very highly
expressedtranscripts.Wethenextendedthereadsto110 nt,theexpectedmeanofthe
CLIP fragments and used the SeqMonk software (www.bioinformatics.bbsrc.ac.uk/
projects/seqmonk) to identify binding regions by using the program’s built-in peak
detection algorithm. Peaks were scored using both a reads per peak scoring scheme
and a maximum depth scoring scheme (effectively the height of the peak) in order to
filter out peaks. For the identification of CUGBP1- and MBNL1-binding regions, we
usedPTB asa negative controland removed peaks present in the PTBdataset as well.
We then selected CUGBP1 peaks that were presentin the two independent CUGBP1
CLIP experiments and MBNL1 peaks that were similarly corroborated by the two
MBNL1 experiments. PTB binding regions were identified by removing peaks that
were present in either of the four CUGBP1 and MBNL1 experiments. Finally, we
restricted the set of binding regions to only those spanning 70–150 bp since this was
the fragment length used in the CLIP experiments. We analyzed each dataset using a
motif analysis tool, MEME
31, using a background Markov model based on the entire
mouse genome.
Weanalyzedthe mappedIlluminareadsand binding regions and mapped them to
UCSC knownGene annotations
51 of the mouse genome (NCBI Build 37.1/mm9) by
writing and running Perl and Excel VBA programs, as well as by running BEDTools
utilities
52.NormalizedcomplexitymapsofCUGBP1/MBNL1/PTB-RNAinteractions
weregeneratedaspreviouslydescribed
30.Forthecontrol,normalizedcomplexitymap
wassimilarly generated by analyzing 100 sets of 15 to50 constitutive exons that were
randomly selected from 118,969 constitutive exons in mm9. To identify enriched
Gene Ontology terms, we used the Database for Annotation, Visualization and
Integrated Discovery (DAVID 6.7)
53,54.
Construction of plasmids. To construct luciferase reporter vectors with the 39 UTR
of Gapdh and Pitx2,3 9 UTRs of these genes were amplified by PCR. Amplified DNA
wasligatedintotheXbaIandBamHIsitesofthepGL3-promotervector(Promega)to
substitute for the 39 UTR of the firefly luciferase gene. DNA fragments harboring GT
and CTG repeats were amplified by self-priming PCR using primers terminating in a
XbaI site, and ligated into the XbaI site to make the pGL3P-Gapdh-39 UTR.
To construct tet-responsive luciferase constructs, the tet-responsive promoter
region was excised from pTRE-Tight vector (Clontech) with XhoI-HindIII site and
cloned into the XhoI-HindIII site of the pGL3-promoter vector with the 39 UTR of
Gapdh and Pitx2. To introduce mutations in 39 UTR of Pitx2 in the luciferase con-
struct, we used the QuikChange site-directed mutagenesis kit (Stratagene).
To construct expression vectors for MBNL1 and CUGBP1, the human MBNL1
cDNA and human CUGBP1 cDNA (Open Biosystems) were subcloned into the
mammalian bidirectional expression vector pBI-CMV2 (Clontech), which should
constitutively expresses the insert and AcGFP1.
RNA interference and transfection. The siRNA duplexes against CUGBP1 and
MBNL1 were synthesized by Sigma. The sense sequences of the siRNAs were as
follows:Cugbp1-1,59-GCUUUGGUUUUGUAAGUUA-39;Cugbp1-2,59-GGCUU-
AAAGUGCAGCUCAA-39; Mbnl1-1, 59-CACUGGAAGUAUGUAGAGA-39; and
Mbnl1-2, 59-GCACAAUGAUUGAUACCAA-39. We purchased the AllStar
NegativeControlsiRNA(1027281)fromQiagen.C2C12cellswereseededon24-well
plates, and transfected with siRNA using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. Tet-off advanced HEK293 cells were seeded on
96-well plates, and were transfected with luciferase reporter gene constructs using
FuGENE 6 (Roche) according to the manufacturer’s instructions. At 48 hrs after
transfection,cells wereeitherharvested forRNAextractionorprocessed forisolation
of total proteins or nuclear extracts.
RT-PCR for splicing analysis. Total RNA was extracted using Trizol (Invitrogen)
according to the manufacturer’s instructions. cDNA was synthesized using an oligo-
dT primer and ReverTra Ace (Toyobo), and PCR amplifications were performed
using GoTaq (Promega) for 30–35 cycles. Sequences of the primers used for PCR are
listed in the Supplementary Table S3. The intensities of PCR-amplified spliced
productswerequantifiedwiththeImageJ1.42qsoftware(NIH).Wethencalculateda
percentage of exon inclusion (% inclusion) as the ratio of the intensity of the upper
band divided by the sum of intensities of all the bands.
Real-time RT-PCR for RNA stability analysis. Total RNA was extracted using
RNeasyminikit(Qiagen)orCellAmpDirectRNAPrepKit(Takara)accordingtothe
manufacturer’sinstructions.cDNAwassynthesizedasdescribedaboveandreal-time
PCR was performed using the Mx3005P QPCR System (Stratagene) and the SYBR
Premix Ex Taq II (Takara). Sequences of the primers used for PCR are listed in
Supplementary Table S4.
Microarray analysis. Total RNA was extracted using the RNeasy mini kit according
to the manufacturer’s instructions. We synthesized and labeled cDNA fragments
from 100 ng of total RNA using the GeneChip WT cDNA Synthesis Kit (Ambion).
The labeled cDNAs were hybrized to the Affymetrix Mouse Exon 1.0 ST Arrays for
splicing analysis orthe Affymetrix Mouse Gene 1.0ST Arrays for analyzing temporal
profiles of expression of CUGBP1/MBNL1-targeted genes following the
manufacturer’s protocols. The robust multichip analysis (RMA) algorithm was used
to normalize the array signals across chips with the Affymetrix Expression Console
software 1.1.2. All microarray data were uploaded to the Gene Expression Omnibus
database (accession numbers, GSE29990 for exon arrays and GSE27583 for
expression arrays).
Western blotting. For preparation of total cell lysates, cells were lysed in buffer A
(10 mM HEPES pH 7.8, 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, 2 mg/ml
Aprotinin, 0.5 mM PMSF, 0.1% NP-40) and incubate on ice for 20 min. After
sonication,sampleswerecentrifuged(15,000 rpm,5 min)andthesupernatantswere
stored at 280uC for further experiments. For preparation of nuclear cell lysates, cells
were suspended in 400 ml of buffer A. Nuclei were pelleted, and the cytoplasmic
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(50 mM HEPES pH 7.8, 420 mM KCl, 0.1 mM EDTA, 5 mM MgCl2, 2% Glycerol,
1 mM DTT,2 mg/ml Aprotinin, and 0.5 mM PMSF). After vortexing and stirring for
20 min at 4uC, the samples were centrifuged, and the supernatants were stored at
280uC. Samples were analyzed on a 10% SDS polyacrylamide gel, and the proteins
were transferred to Immobilon polyvinylidene difluoride membranes (Millipore).
Membranes were blocked with 1% BSA in Tris-buffered saline containing 0.05%
Tween20 (TBST) for 1 hr, incubated for 1 hr with primary antibodies in TBST,
washed three times with TBST, and incubated for 1 hr with horseradish peroxidase-
conjugated anti-mouse or -rabbit immunoglobulin (GE) diluted 155,000 in TBST.
After three washes in TBST, the blot was developed with the enhanced
chemiluminescence system (GE) according to the manufacturer’s instructions.
Luciferase assay. HEK293 cells seeded on a 96 well plate were transfected with 10 ng
of pGL3P-Gapdh-39 UTR with or without GT and CTG repeats, 5 ng of pRL/SV40
(Promega), and 40 ng of pBI-CMV2-based CUGBP1 or MBNL1 expression vector
usingFuGENE6.At48 hrsafterthetransfection,theluciferaseactivitywasmeasured
using the Dual-Luciferase Reporter Assay System (Promega) according to the
manufacturer’s instructions.
1. Licatalosi,D.D.&Darnell,R.B.RNAprocessinganditsregulation:globalinsights
into biological networks. Nat Rev Genet 11, 75–87 (2010).
2. Wang,G.S.&Cooper,T.A.Splicingindisease:disruptionofthesplicingcodeand
the decoding machinery. Nat Rev Genet 8, 749–61 (2007).
3. Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a
trinucleotide (CTG) repeat at the 39 end of a transcript encoding a protein kinase
family member. Cell 68, 799–808 (1992).
4. Day, J. W. & Ranum, L. P. RNA pathogenesis of the myotonic dystrophies.
Neuromuscul Disord 15, 5–16 (2005).
5. Larkin, K. & Fardaei, M. Myotonic dystrophy—a multigene disorder. Brain Res
Bull 56, 389–95 (2001).
6. Lee, J. E. & Cooper, T. A. Pathogenic mechanisms of myotonic dystrophy.
Biochem Soc Trans 37, 1281–6 (2009).
7. Turner, C. & Hilton-Jones, D. The myotonic dystrophies: diagnosis and
management. J Neurol Neurosurg Psychiatry 81, 358–67 (2010).
8. Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n)
expansions associated with myotonic dystrophy. EMBO J 19, 4439–48 (2000).
9. Lin, X. et al. Failure of MBNL1-dependent post-natal splicing transitions in
myotonic dystrophy. Hum Mol Genet 15, 2087–97 (2006).
10. Kuyumcu-Martinez, N. M., Wang, G. S. & Cooper, T. A. Increased steady-state
levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated
hyperphosphorylation. Mol Cell 28, 68–78 (2007).
11.Iwahashi,C.K.etal.ProteincompositionoftheintranuclearinclusionsofFXTAS.
Brain 129, 256–71 (2006).
12. Kalsotra, A. et al. A postnatal switch of CELF and MBNL proteins reprograms
alternativesplicinginthedevelopingheart.ProcNatlAcadSciUSA105,20333–8
(2008).
13. Bland, C. S. et al. Global regulation of alternative splicing during myogenic
differentiation. Nucleic Acids Res (2010).
14. Philips, A. V., Timchenko, L. T. & Cooper, T. A. Disruption of splicing regulated
by a CUG-binding protein in myotonic dystrophy. Science 280, 737–41 (1998).
15. Ho, T. H., Bundman, D., Armstrong, D. L. & Cooper, T. A. Transgenic mice
expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic
dystrophy. Hum Mol Genet 14, 1539–47 (2005).
16.Savkur,R.S.,Philips,A.V.&Cooper,T.A.Aberrantregulationofinsulinreceptor
alternative splicing is associated with insulin resistance in myotonic dystrophy.
Nat Genet 29, 40–7 (2001).
17.Charlet,B.N.etal.Lossofthemuscle-specificchloridechannelintype1myotonic
dystrophy due to misregulated alternative splicing. Mol Cell 10, 45–53 (2002).
18.Begemann,G.etal.muscleblind,agenerequiredforphotoreceptordifferentiation
in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing
proteins. Development 124, 4321–31 (1997).
19. Teplova, M. & Patel, D. J. Structural insights into RNA recognition by the
alternative-splicing regulator muscleblind-like MBNL1. Nat Struct Mol Biol 15,
1343–51 (2008).
20. Ho, T. H. et al. Muscleblind proteins regulate alternative splicing. EMBO J 23,
3103–12 (2004).
21. Cass, D. et al. The four Zn fingers of MBNL1 provide a flexible platform for
recognition of its RNA binding elements. BMC Mol Biol 12, 20 (2011).
22. Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy.
Science 302, 1978–80 (2003).
23. Fugier, C. et al. Misregulated alternative splicing of BIN1 is associated with T
tubule alterations and muscle weakness in myotonic dystrophy. Nature Medicine
17, 720–5 (2011).
24. Moraes, K. C., Wilusz, C. J. & Wilusz, J. CUG-BP binds to RNA substrates and
recruits PARN deadenylase. Rna 12, 1084–91 (2006).
25.Vlasova,I.A.etal.ConservedGU-richelementsmediatemRNAdecaybybinding
to CUG-binding protein 1. Mol Cell 29, 263–70 (2008).
26. Lee, J. E., Lee, J. Y., Wilusz, J., Tian, B. & Wilusz, C. J. Systematic analysis of cis-
elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of
mRNA decay in muscle cells. PLoS One 5, e11201 (2010).
27. Rattenbacher, B. et al. Analysis of CUGBP1 Targets Identifies GU-Repeat
Sequences That Mediate Rapid mRNA Decay. Mol Cell Biol 30, 3970–80 (2010).
28.Timchenko, N.A.,Iakova, P., Cai,Z.J.,Smith, J.R.&Timchenko,L.T.Molecular
basisforimpairedmuscledifferentiationinmyotonicdystrophy.MolCellBiol21,
6927–38 (2001).
29. Timchenko, N. A. et al. Overexpression of CUG triplet repeat-binding protein,
CUGBP1, in mice inhibits myogenesis. J Biol Chem 279, 13129–39 (2004).
30. Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain
alternative RNA processing. Nature 456, 464–9 (2008).
31. Bailey, T. L. & Elkan, C. The value of prior knowledge in discovering motifs with
MEME. Proc Int Conf Intell Syst Mol Biol 3, 21–9 (1995).
32.Marquis,J.etal.CUG-BP1/CELF1requiresUGU-richsequencesforhigh-affinity
binding. Biochem J 400, 291–301 (2006).
33.Du,H.etal.Aberrantalternativesplicingandextracellularmatrixgeneexpression
in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17, 187–93 (2010).
34.Goers,E.S.,Purcell,J.,Voelker, R.B.,Gates,D.P.&Berglund,J.A.MBNL1binds
GCmotifsembeddedinpyrimidinestoregulatealternativesplicing.NucleicAcids
Res (2010).
35. Kino, Y. et al. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG
repeats. Hum Mol Genet 13, 495–507 (2004).
36. Xue, Y. et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy
usedbythegeneralsplicingrepressortomodulateexoninclusionorskipping.Mol
Cell 36, 996–1006 (2009).
37.Hamada,H.,Meno,C.,Watanabe,D.&Saijoh,Y.Establishmentofvertebrateleft-
right asymmetry. Nat Rev Genet 3, 103–13 (2002).
38.Yashiro,K.,Shiratori,H.&Hamada,H.Haemodynamicsdeterminedbyagenetic
programmegovernasymmetric development of the aortic arch.Nature 450,285–
8 (2007).
39. Dong, F. et al. Pitx2 promotes development of splanchnic mesoderm-derived
branchiomeric muscle. Development 133, 4891–9 (2006).
40. Shih, H. P., Gross, M. K. & Kioussi, C. Cranial muscle defects of Pitx2 mutants
result from specification defects in the first branchial arch. Proceedings of the
NationalAcademyofSciencesoftheUnitedStatesofAmerica104,5907–12(2007).
41. Gherzi, R. et al. Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA
decay during muscle cell differentiation. Cell Death and Differentiation 17, 975–
83 (2010).
42. Chen, H. H., Xu, J., Safarpour, F. & Stewart, A. F. LMO4 mRNA stability is
regulated by extracellular ATP in F11 cells. Biochem Biophys Res Commun 357,
56–61 (2007).
43.Zhang,L., Lee,J.E., Wilusz,J.&Wilusz,C.J.TheRNA-binding protein CUGBP1
regulatesstabilityoftumornecrosisfactormRNAinmusclecells:implicationsfor
myotonic dystrophy. J Biol Chem 283, 22457–63 (2008).
44. Horb, L. D. & Horb, M. E. BrunoL1 regulates endoderm proliferation through
translational enhancement of cyclin A2 mRNA. Dev Biol (2010).
45. Yeo, G. W. et al. An RNA code for the FOX2 splicing regulator revealed by
mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol 16, 130–7
(2009).
46. Llorian, M. et al. Position-dependent alternative splicing activity revealed by
global profiling of alternative splicing events regulated by PTB. Nat Struct Mol
Biol 17, 1114–23 (2010).
47.Hino,S.etal.MolecularmechanismsresponsibleforaberrantsplicingofSERCA1
in myotonic dystrophy type 1. Hum Mol Genet 16, 2834–43 (2007).
48. Sen, S. et al. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11
inclusion via binding to a downstream evolutionarily conserved intronic
enhancer. J Biol Chem 285, 25426–37 (2010).
49.Ule,J.,Jensen,K.,Mele,A.&Darnell,R.B.CLIP:amethodforidentifyingprotein-
RNA interaction sites in living cells. Methods 37, 376–86 (2005).
50.Li,H.&Durbin,R.Fastandaccuratelong-readalignmentwithBurrows-Wheeler
transform. Bioinformatics 26, 589–95 (2010).
51. Rhead, B. et al. The UCSC Genome Browser database: update 2010. Nucleic Acids
Res 38, D613–9 (2010).
52. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing
genomic features. Bioinformatics 26, 841–2 (2010).
53. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4,
44–57 (2009).
54. Dennis, G., Jr. et al. DAVID: Database for Annotation, Visualization, and
Integrated Discovery. Genome Biol 4, P3 (2003).
Acknowledgements
This work was supported by a JST-DASTI joint grant entitled ‘‘Strategic Japanese-Danish
Cooperative Program on Molecular Medical Research’’, by Grants-in-Aid from the MEXT
andMHLWofJapan,andbyagrantfromtheDanishMedicalResearchCouncil(FSSGrant
no. 271-07-342).
Author contributions
A.M., H.S.A, T.O., and M.I. performed the experiments. A.M., T.K.D., B.S.A., and K.O.
analyzed the data. A.M., T.K.D., B.S.A. and K.O. prepared the manuscript. All authors
reviewed the manuscript.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 209 | DOI: 10.1038/srep00209 9Additional information
Accession codes: All HITS-CLIP data were registered in ArrayExpress with an accession
number E-MTAB-414 and in ENA with an accession number ERP000789.
All microarray data were uploaded to the Gene Expression Omnibus database with
accession numbers, GSE29990 for exon arrays and GSE27583 for expression arrays.
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: The authors declare no competing financial
interests.
License: This work is licensed under a Creative Commons
Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this
license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
How to cite this article: Masuda, A. et al. CUGBP1 and MBNL1 preferentially bind to
39 UTRs and facilitate mRNA decay. Sci. Rep. 2, 209; DOI:10.1038/srep00209 (2012).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 209 | DOI: 10.1038/srep00209 10